Back
4D Molecular Therapeutics, Inc. Stock Price Chart
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
24
FDMT
4D Molecular Therapeutics, Inc.
Last Price:
$8.67
Seasonality Move:
0.56%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight selling pressure.
4D Molecular Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.21 | Sell |
| 20-day SMA: | 10.58 | Sell |
| 50-day SMA: | 10.64 | Sell |
| 200-day SMA: | 6.3 | Buy |
| 8-day EMA: | 9.84 | Sell |
| 20-day EMA: | 10.33 | Sell |
| 50-day EMA: | 10.1 | Sell |
| 200-day EMA: | 8.25 | Buy |
4D Molecular Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 37.01 | Sell |
| Chaikin Money Flow: | -360388 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.85 - 11.31) | Sell |
| Bollinger Bands (100): | (6.83 - 10.87) | Sell |
4D Molecular Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for 4D Molecular Therapeutics, Inc. Stock
Is 4D Molecular Therapeutics, Inc. Stock a Buy?
-
4D Molecular Therapeutics, Inc. share price is 8.68 while FDMT 8-day simple moving average is 10.21, which is a Sell signal.
-
The stock price of FDMT is 8.68 while 4D Molecular Therapeutics, Inc. 20-day SMA is 10.58, which makes it a Sell.
-
4D Molecular Therapeutics, Inc. 50-day simple moving average is 10.64 while FDMT share price is 8.68, making it a Sell technically.
-
FDMT stock price is 8.68 and 4D Molecular Therapeutics, Inc. 200-day simple moving average is 6.30, creating a Buy signal.
FDMT Technical Analysis vs Fundamental Analysis
Sell
24
4D Molecular Therapeutics, Inc. (FDMT)
is a Sell
Is 4D Molecular Therapeutics, Inc. a Buy or a Sell?
-
4D Molecular Therapeutics, Inc. stock is rated a SellThe current 4D Molecular Therapeutics, Inc. [FDMT] share price is $8.68. The Score for FDMT is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
4D Molecular Therapeutics, Inc. Stock Info
Market Cap:
495.9M
Price in USD:
8.68
Share Volume:
4.8M
4D Molecular Therapeutics, Inc. 52-Week Range
52-Week High:
12.34
52-Week Low:
2.24
Sell
24
4D Molecular Therapeutics, Inc. (FDMT)
is a Sell
4D Molecular Therapeutics, Inc. Share Price Forecast
-
What is the 4D Molecular Therapeutics, Inc. stock price today?The 4D Molecular Therapeutics, Inc. stock price is 8.68 USD today.
-
Will FDMT stock go up or go down?4D Molecular Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is 4D Molecular Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, 4D Molecular Therapeutics, Inc. is overvalued.
Is 4D Molecular Therapeutics, Inc. Stock a Buy?
-
4D Molecular Therapeutics, Inc. share price is 8.68 while FDMT 8-day exponential moving average is 9.84, which is a Sell signal.
-
The stock price of FDMT is 8.68 while 4D Molecular Therapeutics, Inc. 20-day EMA is 10.33, which makes it a Sell.
-
4D Molecular Therapeutics, Inc. 50-day exponential moving average is 10.10 while FDMT share price is 8.68, making it a Sell technically.
-
FDMT stock price is 8.68 and 4D Molecular Therapeutics, Inc. 200-day simple moving average is 8.25, creating a Buy signal.
Fundamental Analysis of 4D Molecular Therapeutics, Inc.
Is 4D Molecular Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and a decrease next year of $0.22 per share.
Technical Analysis of 4D Molecular Therapeutics, Inc.
Should I short 4D Molecular Therapeutics, Inc. stock?
-
FDMT Moving Average Covergence Divergence (MACD) indicator is -0.27, suggesting 4D Molecular Therapeutics, Inc. is a Sell
-
4D Molecular Therapeutics, Inc. Relative Strength Index (RSI) is 37.01, which suggest 4D Molecular Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for 4D Molecular Therapeutics, Inc. is (9.85 - 11.31), which suggest 4D Molecular Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for 4D Molecular Therapeutics, Inc. is (6.83 - 10.87), which suggest 4D Molecular Therapeutics, Inc. is a Sell
* 4D Molecular Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.